Title: Expression of CD133 and CD44 proteins in gastric stromal tumors and their clinical significances
Abstract: Objective
To investigate the expression of CD133 and CD44 proteins in gastric stromal tumors (GST) and their clinical significances.
Methods
The expression of CD44 and CD133 proteins in the GST tissues of 112 patients was detected by immunohistochemical staining. The relation between the expression of CD44 and CD133 proteins and the clinicopathological characters was analyzed. The survival and prognosis of GST were also analyzed.
Results
Both CD44 and CD133 were expressed on the cell membranes. The expression rates of CD44 and CD133 were 58.04% (65/112) and 42.86% (48/112) separately; the co-expression rate of CD44 and CD133 was 27.68% (31/112). CD44 and CD133 were negative in normal peritumoral tissues. No correlation was found between CD44 and CD133 and the clinicopathological parameters including gender, age and lymphatic vessel invasion (all P > 0.05), but the expression levels of CD44 and CD133 in patients with the mitotic count ≥ 5/50 high-power field, large diameter and vascular invasion were significantly higher (all P 0.05), but the co-expression level of CD44 and CD133 in patients with tumor diameter ≥5 cm was significantly higher than that in patients with tumor diameter < 5 cm (χ2=5.040, P = 0.025). The overall survival rate of the patients with co-expression of CD44 and CD133 was shorter than that in other groups (χ2 = 8.758, P = 0.001). No correlation was found between CD44 and CD133 expression (r = 0.126, P = 0.210). Multivariate analysis with the Cox regression models showed that the tumor diameter ≥5 cm (P = 0.042) and co-expression of CD44 and CD133 (P = 0.003) were significantly associated with poor prognosis.
Conclusion
CD44 and CD133 as robust cancer stem cell markers in GST might be the prognostic factors.
Key words:
Gastric stromal tumors; Prognosis; Antigens, CD44; Antigens, CD133
Publication Year: 2017
Publication Date: 2017-08-28
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot